BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 6 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,184 | -37.0% | 58,600 | -38.3% | 0.00% | -42.9% |
| Q2 2023 | $8,225 | +71.9% | 94,900 | +92.9% | 0.01% | +75.0% |
| Q1 2023 | $4,784 | -39.8% | 49,200 | -35.9% | 0.00% | -55.6% |
| Q4 2022 | $7,948 | -99.8% | 76,800 | +25.1% | 0.01% | +50.0% |
| Q3 2022 | $5,204,000 | +43.1% | 61,400 | +39.9% | 0.01% | +50.0% |
| Q2 2022 | $3,637,000 | +49.8% | 43,900 | +39.4% | 0.00% | +100.0% |
| Q1 2022 | $2,428,000 | -41.9% | 31,500 | -33.4% | 0.00% | -50.0% |
| Q4 2021 | $4,178,000 | +42.3% | 47,300 | +35.1% | 0.00% | +33.3% |
| Q3 2021 | $2,936,000 | +0.5% | 35,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,920,000 | -48.6% | 35,000 | +4554.3% | 0.00% | -70.0% |
| Q1 2021 | $5,678,000 | -68.1% | 752 | -62.9% | 0.01% | -56.5% |
| Q4 2020 | $17,774,000 | +131.8% | 2,027 | +101.1% | 0.02% | +130.0% |
| Q3 2020 | $7,668,000 | +17.8% | 1,008 | +90.9% | 0.01% | 0.0% |
| Q2 2020 | $6,512,000 | +57.0% | 528 | +7.5% | 0.01% | +42.9% |
| Q1 2020 | $4,148,000 | +45.2% | 491 | +45.3% | 0.01% | +16.7% |
| Q4 2019 | $2,857,000 | +60.6% | 338 | +28.0% | 0.01% | +20.0% |
| Q3 2019 | $1,779,000 | +18.0% | 264 | +50.0% | 0.01% | +25.0% |
| Q2 2019 | $1,507,000 | +109.6% | 176 | +117.3% | 0.00% | +100.0% |
| Q1 2019 | $719,000 | -45.2% | 81 | -47.4% | 0.00% | -50.0% |
| Q4 2018 | $1,311,000 | -24.0% | 154 | -13.5% | 0.00% | -33.3% |
| Q3 2018 | $1,726,000 | -46.6% | 178 | -48.1% | 0.01% | -53.8% |
| Q2 2018 | $3,231,000 | +13947.8% | 343 | +444.4% | 0.01% | +1200.0% |
| Q1 2018 | $23,000 | -62.3% | 63 | -60.1% | 0.00% | -66.7% |
| Q4 2017 | $61,000 | -33.7% | 158 | +11.3% | 0.00% | -25.0% |
| Q3 2017 | $92,000 | +268.0% | 142 | +79.7% | 0.00% | +300.0% |
| Q2 2017 | $25,000 | -26.5% | 79 | -31.3% | 0.00% | 0.0% |
| Q1 2017 | $34,000 | -56.4% | 115 | -30.7% | 0.00% | -80.0% |
| Q4 2016 | $78,000 | +39.3% | 166 | -30.5% | 0.01% | +25.0% |
| Q3 2016 | $56,000 | +143.5% | 239 | -34.7% | 0.00% | +100.0% |
| Q2 2016 | $23,000 | -83.7% | 366 | -16.4% | 0.00% | -81.8% |
| Q1 2016 | $141,000 | -31.6% | 438 | +89.6% | 0.01% | -31.2% |
| Q4 2015 | $206,000 | +17.7% | 231 | -56.4% | 0.02% | +23.1% |
| Q3 2015 | $175,000 | -68.4% | 530 | +60.6% | 0.01% | -71.7% |
| Q2 2015 | $553,000 | -42.9% | 330 | -10.1% | 0.05% | -59.3% |
| Q1 2015 | $969,000 | +143.5% | 367 | +92.1% | 0.11% | +135.4% |
| Q4 2014 | $398,000 | – | 191 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 2,027 | $17,774,000 | 0.02% |
| Hudson Bay Capital Management LP | 40,000 | $3,508,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 103,800 | $9,102,000 | 0.02% |
| IMC-Chicago, LLC | 64,200 | $5,630,000 | 0.01% |
| JPMORGAN CHASE & CO | 353,400 | $30,990,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |